Biodexa Pharmaceuticals American Depositary Shs Stock Forecast

Sell candidate since Oct 28, 2025 Loss -19.59%

The Biodexa Pharmaceuticals Plc American stock price fell by -0.365% on the last day (Monday, 17th Nov 2025) from $5.48 to $5.46. During the last trading day the stock fluctuated 5.32% from a day low at $5.45 to a day high of $5.74. The price has fallen in 6 of the last 10 days and is down by -10.2% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 thousand shares and in total, 10 thousand shares were bought and sold for approximately $53.58 thousand.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $5.11 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Biodexa Pharmaceuticals Plc American stock with a 90% probability to be traded between $5.19 and $11.12 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stock seldom manage to go directly from the bottom of a trend up to the top. Stock turning up in the middle of a horizontal trend are therefore considered to be potential runners.

BDRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, November 13, 2025, and so far it has risen 6.85%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biodexa Pharmaceuticals Plc American stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $6.81. On a fall, the stock will find some support from the short-term average at $5.40. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Biodexa Pharmaceuticals Plc American stock

Biodexa Pharmaceuticals Plc American finds support from accumulated volume at $5.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.290 between high and low, or 5.32%. For the last week the stock has had daily average volatility of 7.27%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BDRX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Biodexa Pharmaceuticals Plc American Depositary Shs to open at $5.55, and during the day (based on 14 day Average True Range), to move between $5.14 and $5.78, which gives a possible trading interval of +/-$0.643 (+/-12.52%) up or down from last closing price. If Biodexa Pharmaceuticals Plc American Depositary Shs takes out the full calculated possible swing range there will be an estimated 12.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.40 (1.10%) than the resistance at $5.94 (8.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Biodexa Pharmaceuticals Plc American Depositary Shs stock A Buy?

Biodexa Pharmaceuticals Plc American holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.126 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $5.55 ( 1.65%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk